Europe Constrained Peptide Drugs Market Analysis and Forecast, 2024-2040: Market to Grow by Over $6.5 Billion at a CAGR of 41.55%, Driven by Innovative Pipeline Drugs that Target More than Receptors Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The "Europe Constrained Peptide Drugs Market: Analysis and Forecast, 2024-2040" report has been added to ResearchAndMarkets.com's offering.The market size...

Global Constrained Peptide Drugs Market Outlook 2024-2030: Key Insights Into Peptide Type and End-user Trends Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Constrained Peptide Drugs Market by Peptide Type (Macrocyclic, Stapled), End-User (Hospitals & Clinics, Pharmaceutical Companies) - Forecast...

Global Peptide Cancer Drug Market 2023: New Technological Innovations Drive Growth Dublin, July 06, 2023 (GLOBE NEWSWIRE) -- The "Global Peptide Cancer Drug Market, Dosage, Price, Sales and Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's...

Constrained Peptide Drugs Global Market 2023: Sector is Expected to Reach $17.28 Billion by 2030 at a CAGR of 38.94% Dublin, June 09, 2023 (GLOBE NEWSWIRE) -- The "Constrained Peptide Drugs Market - A Global and Regional Analysis: Focus on Peptide Type, Product, and Region-Wise Analysis - Analysis and Forecast,...